Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis.
about
Targeting inflammation in pancreatic cancer: Clinical translationThe gastrointestinal tumor microenvironmentHarnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesisChemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesDuality of the immune response in cancer: lessons learned from skinCXCR2: a target for pancreatic cancer treatment?Live imaging and gene expression analysis in zebrafish identifies a link between neutrophils and epithelial to mesenchymal transitionGiardia duodenalis infection reduces granulocyte infiltration in an in vivo model of bacterial toxin-induced colitis and attenuates inflammation in human intestinal tissueStructural Insights into Neutrophilic Migration Revealed by the Crystal Structure of the Chemokine Receptor CXCR2 in Complex with the First PDZ Domain of NHERF1Neutrophils and Granulocytic MDSC: The Janus God of Cancer ImmunotherapyGenetically engineered mouse models in oncology research and cancer medicineThe Multifaceted Roles Neutrophils Play in the Tumor MicroenvironmentTIGAR is required for efficient intestinal regeneration and tumorigenesisLocalized bacterial infection induces systemic activation of neutrophils through Cxcr2 signaling in zebrafish.The role of neutrophil myeloperoxidase in models of lung tumor development.Tumor associated macrophages and neutrophils in tumor progression.Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer.Dual-specificity phosphatase 5 regulates nuclear ERK activity and suppresses skin cancer by inhibiting mutant Harvey-Ras (HRasQ61L)-driven SerpinB2 expressionIdentification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer.CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signalingOverexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival.A pepducin derived from the third intracellular loop of FPR2 is a partial agonist for direct activation of this receptor in neutrophils but a full agonist for cross-talk triggered reactivation of FPR2.IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cellsResistance of R-Ras knockout mice to skin tumour inductionPharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumorsPharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer's disease.Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis.NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases.Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in MiceCXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.The role of tissue resident cells in neutrophil recruitmentIdentification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancerNF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells.Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms.The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice.Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent mannerHost Cxcr2-dependent regulation of mammary tumor growth and metastasis
P2860
Q26751686-B4E0A5CB-7CE3-4676-8479-65D338AAE952Q26827391-26F21001-1C16-4E96-9E70-314CAC81DA2FQ26861766-CF4BBF79-FD15-4E83-AA04-2175663F1BBEQ26866236-3F6C2A83-9C8D-4E0A-AC8E-1499900E0985Q26999379-B01E2CAE-53A7-455B-AADF-F26A1760AA87Q27021588-E9768876-1833-4E92-9B94-75F7FDA33CD0Q27330504-FB00A58C-05EC-4558-A4EA-D176B79DB237Q27342150-7DF4C11D-8555-45D0-ADE9-D7F244562EA6Q27680153-E73CE892-1CCC-4DB7-93AA-4130D486F5E2Q28069360-6780C413-FA77-43CE-8395-974DE6603895Q28079323-CB1CD346-C56F-478C-AE6E-6E026FE537FBQ28241308-8D0C57AA-ADA1-4DC7-ACF2-C3061781016AQ28585472-15344048-10ED-4844-B647-F17B316C2F65Q30580381-5ECB8214-1CEB-43B3-9F53-CD7B9D95D33DQ33820306-7E56A049-8630-4E20-BB3E-1DF891B070E7Q34306107-BF2472D8-038D-4C93-AD23-4D49778AC976Q34394197-66CCECE2-9C67-4235-8189-5E9CCAD46451Q34555169-EBB90637-51B7-4CED-8C1E-1B78FC305A25Q34793029-48843840-6921-480E-A872-200F00B443D2Q35044351-F57451A8-10A9-416F-A198-A2A8CBDFA647Q35078196-90E22FAB-F289-41E6-8D41-300FAE14B4D4Q35223880-011E2AD5-7401-4B74-AD26-601D19068BC7Q35320697-94244554-FEB3-423B-96A6-8C260F1E092EQ35607293-E72F74B8-7383-418D-A78B-9F5F33AA1016Q35809230-D96C38EF-2F87-43DA-8211-DDE26F6EC9BEQ35832158-9028F2A5-A870-4EF9-84EE-70B67D6D5122Q35931230-8CFC5A75-7A09-4E11-971D-FD4E25EB4998Q35955155-AC925FE5-A89F-4F0E-A5C2-DD70035D91F1Q35956535-99C371DC-768D-45B0-A554-63FB86D7C92DQ35983991-7777F4B0-14DE-4068-AD93-F614992CCD65Q36041701-4D9360BC-4E01-4AC4-AAB3-89BBFC4A5370Q36053093-69E7E26E-6577-4C24-A9E3-26AAADA21C0AQ36069872-A30AF19F-7622-4B98-8069-6D5A1015CBEDQ36159383-80823E43-EA84-4F0F-8438-9B311738B724Q36210826-AFC98DE4-C42F-471A-A740-F7FAD67E0605Q36422289-EFFCC6B6-2137-459F-9D5D-D712890ECA31Q36432415-DAA29575-A73E-4B70-821C-D39DB80F4975Q36597522-9523436E-E6E2-4DFC-A682-8BF4B3C2BA6BQ36711023-74505229-AF77-4D91-B57B-04E5CCC15EA2Q36767227-A596EC88-A535-4194-8CF7-118C34855651
P2860
Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Inhibition of CXCR2 profoundly ...... and spontaneous tumorigenesis.
@ast
Inhibition of CXCR2 profoundly ...... and spontaneous tumorigenesis.
@en
type
label
Inhibition of CXCR2 profoundly ...... and spontaneous tumorigenesis.
@ast
Inhibition of CXCR2 profoundly ...... and spontaneous tumorigenesis.
@en
prefLabel
Inhibition of CXCR2 profoundly ...... and spontaneous tumorigenesis.
@ast
Inhibition of CXCR2 profoundly ...... and spontaneous tumorigenesis.
@en
P2093
P2860
P50
P356
P1476
Inhibition of CXCR2 profoundly ...... and spontaneous tumorigenesis.
@en
P2093
Andreas Jung
Colin W Steele
Jens Neumann
Sudipto Das
Thomas Jamieson
P2860
P304
P356
10.1172/JCI61067
P407
P577
2012-08-27T00:00:00Z